BOSTON (AP) -- A former chief executive of Biopure Corp. has agreed to pay $120,000 to settle a federal complaint alleging he made misleading public statements about his company’s prospects of winning approval for a synthetic blood product.
BOSTON (AP) -- A former chief executive of Biopure Corp. has agreed to pay $120,000 to settle a federal complaint alleging he made misleading public statements about his company’s prospects of winning approval for a synthetic blood product.
